$BRL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BARR PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BARR PHARMACEUTICALS INC. Get notifications about new insider transactions in BARR PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 7 ... 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 17 2008 | BRL | BARR PHARMACEUTICA ... | BOGDA MICHAEL | President & COO | Buy | M | 26.58 | 11,277 | 299,743 | 13,563 | 2.3 K to 13.6 K (+493.31 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Option Exercise | M | 31.29 | 33,750 | 1,055,926 | 55,625 | |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Option Exercise | M | 54.25 | 5,000 | 271,250 | 89,375 | |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Option Exercise | M | 57.35 | 10,000 | 573,500 | 94,375 | |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.76 | 100 | 6,476 | 0 | 100 to 0 (-100.00 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.75 | 11,700 | 757,575 | 100 | 11.8 K to 100 (-99.15 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.75 | 500 | 32,373 | 11,800 | 12.3 K to 11.8 K (-4.07 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.74 | 1,000 | 64,740 | 12,300 | 13.3 K to 12.3 K (-7.52 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.74 | 100 | 6,474 | 13,300 | 13.4 K to 13.3 K (-0.75 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.73 | 543 | 35,148 | 13,400 | 13.9 K to 13.4 K (-3.89 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.73 | 1,157 | 74,887 | 13,943 | 15.1 K to 13.9 K (-7.66 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.72 | 743 | 48,087 | 15,100 | 15.8 K to 15.1 K (-4.69 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.72 | 100 | 6,472 | 15,873 | 16 K to 15.9 K (-0.63 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.71 | 200 | 12,942 | 15,943 | 16.1 K to 15.9 K (-1.24 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.70 | 1,700 | 109,990 | 16,143 | 17.8 K to 16.1 K (-9.53 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.70 | 2,000 | 129,390 | 17,843 | 19.8 K to 17.8 K (-10.08 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.69 | 200 | 12,938 | 19,843 | 20 K to 19.8 K (-1.00 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.68 | 4,100 | 265,188 | 20,043 | 24.1 K to 20 K (-16.98 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.68 | 200 | 12,935 | 24,143 | 24.3 K to 24.1 K (-0.82 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.67 | 400 | 25,868 | 24,343 | 24.7 K to 24.3 K (-1.62 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.67 | 200 | 12,933 | 24,743 | 24.9 K to 24.7 K (-0.80 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.66 | 600 | 38,796 | 24,943 | 25.5 K to 24.9 K (-2.35 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.65 | 100 | 6,465 | 25,543 | 25.6 K to 25.5 K (-0.39 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.61 | 500 | 32,305 | 25,643 | 26.1 K to 25.6 K (-1.91 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.60 | 15,050 | 972,230 | 26,143 | 41.2 K to 26.1 K (-36.54 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.57 | 100 | 6,457 | 41,193 | 41.3 K to 41.2 K (-0.24 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.56 | 500 | 32,280 | 41,293 | 41.8 K to 41.3 K (-1.20 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Sell | S | 64.55 | 6,957 | 449,074 | 41,793 | 48.8 K to 41.8 K (-14.27 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Buy | M | 64.70 | 33,750 | 2,183,625 | 48,750 | 15 K to 48.8 K (+225.00 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Buy | M | 54.25 | 5,000 | 271,250 | 15,000 | 10 K to 15 K (+50.00 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Insider | Buy | M | 57.35 | 10,000 | 573,500 | 10,000 | 0 to 10 K |
Nov 14 2008 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Insider | Option Exercise | M | 28.14 | 5,000 | 140,700 | 99,375 | |
Nov 14 2008 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Insider | Buy | M | 28.14 | 5,000 | 140,700 | 11,875 | 6.9 K to 11.9 K (+72.73 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Insider | Option Exercise | M | 8.87 | 6,875 | 61,004 | 104,375 | |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Insider | Buy | M | 8.87 | 6,875 | 61,004 | 6,875 | 0 to 6.9 K |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Insider | Option Exercise | M | 8.87 | 10,000 | 88,733 | 111,250 | |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Insider | Sell | S | 64.50 | 10,000 | 645,000 | 0 | 10 K to 0 (-100.00 %) |
Nov 13 2008 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Insider | Buy | M | 8.87 | 10,000 | 88,733 | 10,000 | 0 to 10 K |
Nov 12 2008 | BRL | BARR PHARMACEUTICA ... | CHEFITZ HAROLD N | Insider | Option Exercise | M | 26.76 | 16,875 | 451,575 | 53,750 | |
Nov 12 2008 | BRL | BARR PHARMACEUTICA ... | CHEFITZ HAROLD N | Insider | Option Exercise | M | 33.70 | 16,875 | 568,688 | 70,625 | |
Nov 12 2008 | BRL | BARR PHARMACEUTICA ... | CHEFITZ HAROLD N | Insider | Buy | M | 26.76 | 16,875 | 451,575 | 16,875 | 0 to 16.9 K |
Nov 12 2008 | BRL | BARR PHARMACEUTICA ... | CHEFITZ HAROLD N | Insider | Buy | M | 33.70 | 16,875 | 568,688 | 16,875 | 0 to 16.9 K |
Sep 10 2008 | BRL | BARR PHARMACEUTICA ... | Sawyer Timothy | Executive VP | Option Exercise | D | 10.05 | 1 | 10 | 148,487 | |
Jul 21 2008 | BRL | BARR PHARMACEUTICA ... | FRANKOVIC RICHARD | Director | Option Exercise | M | 33.70 | 20,000 | 674,000 | 84,375 | |
Jul 21 2008 | BRL | BARR PHARMACEUTICA ... | FRANKOVIC RICHARD | Director | Sell | S | 58.00 | 20,000 | 1,160,000 | 0 | 20 K to 0 (-100.00 %) |
Jul 21 2008 | BRL | BARR PHARMACEUTICA ... | FRANKOVIC RICHARD | Director | Buy | M | 33.70 | 20,000 | 674,000 | 20,000 | 0 to 20 K |
Jul 16 2008 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Director | Gift | G | 44.51 | 100,000 | 4,451,000 | 58,960 | 159 K to 59 K (-62.91 %) |
May 21 2008 | BRL | BARR PHARMACEUTICA ... | BOGDA MICHAEL | President & COO | Option Exercise | M | 26.61 | 3,757 | 99,986 | 0 | |
May 21 2008 | BRL | BARR PHARMACEUTICA ... | BOGDA MICHAEL | President & COO | Buy | M | 26.61 | 3,757 | 99,986 | 5,569 | 1.8 K to 5.6 K (+207.34 %) |
May 16 2008 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Director | Option Exercise | A | 39.76 | 10,000 | 397,600 | 10,000 | |
May 16 2008 | BRL | BARR PHARMACEUTICA ... | SEAVER PETER | Director | Option Exercise | A | 39.76 | 10,000 | 397,600 | 10,000 | |
May 16 2008 | BRL | BARR PHARMACEUTICA ... | GILMORE JAMES III | Director | Option Exercise | A | 39.76 | 10,000 | 397,600 | 10,000 | |
May 16 2008 | BRL | BARR PHARMACEUTICA ... | FRANKOVIC RICHARD | Director | Option Exercise | A | 39.76 | 10,000 | 397,600 | 10,000 | |
May 16 2008 | BRL | BARR PHARMACEUTICA ... | CHEFITZ HAROLD N | Director | Option Exercise | A | 39.76 | 10,000 | 397,600 | 10,000 | |
May 15 2008 | BRL | BARR PHARMACEUTICA ... | MUNDKUR CHRISTINE | Chief Executive Off ... | Option Exercise | M | 35.01 | 2,856 | 99,989 | 0 | |
May 15 2008 | BRL | BARR PHARMACEUTICA ... | MUNDKUR CHRISTINE | Chief Executive Off ... | Option Exercise | M | 26.58 | 11,278 | 299,769 | 0 | |
May 15 2008 | BRL | BARR PHARMACEUTICA ... | MUNDKUR CHRISTINE | Chief Executive Off ... | Buy | M | 35.01 | 2,856 | 99,989 | 59,565 | 56.7 K to 59.6 K (+5.04 %) |
May 15 2008 | BRL | BARR PHARMACEUTICA ... | MUNDKUR CHRISTINE | Chief Executive Off ... | Buy | M | 26.58 | 11,278 | 299,769 | 56,709 | 45.4 K to 56.7 K (+24.82 %) |
May 13 2008 | BRL | BARR PHARMACEUTICA ... | KILLION FREDERICK | General Counsel | Option Exercise | S | 30.19 | 10,000 | 301,867 | 6,560 | |
May 13 2008 | BRL | BARR PHARMACEUTICA ... | KILLION FREDERICK | General Counsel | Grant | A | 30.19 | 10,000 | 301,867 | 11,589 | 1.6 K to 11.6 K (+629.33 %) |
Mar 13 2008 | BRL | BARR PHARMACEUTICA ... | Kirk Sigurd | Sr VP Finance & Cor ... | Option Exercise | A | 49.22 | 27,969 | 1,376,634 | 27,969 | |
Mar 13 2008 | BRL | BARR PHARMACEUTICA ... | Kirk Sigurd | Sr VP Finance & Cor ... | Option Exercise | A | 49.22 | 2,031 | 99,966 | 2,031 | |
Mar 06 2008 | BRL | BARR PHARMACEUTICA ... | MCKEE WILLIAM | Sr.VP, CFO & Treasu ... | Option Exercise | A | 49.22 | 72,969 | 3,591,534 | 72,969 | |
Mar 06 2008 | BRL | BARR PHARMACEUTICA ... | MCKEE WILLIAM | Sr.VP, CFO & Treasu ... | Option Exercise | A | 49.22 | 2,031 | 99,966 | 2,031 | |
Mar 06 2008 | BRL | BARR PHARMACEUTICA ... | Wilkinson George Fred | President & COO | Option Exercise | A | 49.22 | 59,999 | 2,953,151 | 59,999 | |
Mar 06 2008 | BRL | BARR PHARMACEUTICA ... | Wilkinson George Fred | President & COO | Option Exercise | A | 49.22 | 1 | 49 | 1 | |
Mar 06 2008 | BRL | BARR PHARMACEUTICA ... | Gioia Philip | Sr VP,Generic Sales ... | Option Exercise | A | 49.22 | 21,969 | 1,081,314 | 21,969 | |
Mar 06 2008 | BRL | BARR PHARMACEUTICA ... | Gioia Philip | Sr VP,Generic Sales ... | Option Exercise | A | 49.22 | 2,031 | 99,966 | 2,031 | |
Mar 06 2008 | BRL | BARR PHARMACEUTICA ... | Greenman Jane F | Executive VP, Globa ... | Option Exercise | A | 49.22 | 42,969 | 2,114,934 | 42,969 | |
Mar 06 2008 | BRL | BARR PHARMACEUTICA ... | Greenman Jane F | Executive VP, Globa ... | Option Exercise | A | 49.22 | 2,031 | 99,966 | 2,031 | |
Mar 06 2008 | BRL | BARR PHARMACEUTICA ... | KILLION FREDERICK | General Counsel | Option Exercise | A | 49.22 | 42,969 | 2,114,934 | 42,969 | |
Mar 06 2008 | BRL | BARR PHARMACEUTICA ... | KILLION FREDERICK | General Counsel | Option Exercise | A | 49.22 | 2,031 | 99,966 | 2,031 | |
Mar 06 2008 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Option Exercise | A | 49.22 | 147,969 | 7,283,034 | 147,969 | |
Mar 06 2008 | BRL | BARR PHARMACEUTICA ... | DOWNEY BRUCE | Chairman & CEO | Option Exercise | A | 49.22 | 2,031 | 99,966 | 2,031 | |
Mar 06 2008 | BRL | BARR PHARMACEUTICA ... | Covic Zeljko | COO of Pliva d.d. | Option Exercise | A | 49.22 | 35,469 | 1,745,784 | 35,469 | |
Mar 06 2008 | BRL | BARR PHARMACEUTICA ... | Covic Zeljko | COO of Pliva d.d. | Option Exercise | A | 49.22 | 2,031 | 99,966 | 2,031 | |
Dec 18 2007 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Director | Gift | G | 53.87 | 800 | 43,096 | 158,960 | 159.8 K to 159 K (-0.50 %) |
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 16,321 | 433,812 | 0 | ||
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 15,000 | 398,700 | 16,321 | ||
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | M | 54.76 | 1 | 55 | 133,077 | 133.1 K to 133.1 K (0.00 %) | |
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | M | 54.74 | 7,020 | 384,302 | 133,078 | 140.1 K to 133.1 K (-5.01 %) | |
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | M | 54.49 | 9,300 | 506,740 | 140,098 | 149.4 K to 140.1 K (-6.22 %) | |
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 16,321 | 433,812 | 149,398 | 133.1 K to 149.4 K (+12.26 %) | |
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 54.31 | 5,000 | 271,551 | 133,077 | 138.1 K to 133.1 K (-3.62 %) | |
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 53.95 | 10,000 | 539,500 | 138,077 | 148.1 K to 138.1 K (-6.75 %) | |
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 15,000 | 398,700 | 148,077 | 133.1 K to 148.1 K (+11.27 %) | |
Nov 02 2007 | BRL | BARR PHARMACEUTICA ... | FRANKOVIC RICHARD | Director | Option Exercise | M | 13.45 | 5,764 | 77,507 | 0 | |
Nov 02 2007 | BRL | BARR PHARMACEUTICA ... | FRANKOVIC RICHARD | Director | Sell | S | 58.00 | 5,764 | 334,312 | 2,089 | 7.9 K to 2.1 K (-73.40 %) |
Nov 02 2007 | BRL | BARR PHARMACEUTICA ... | FRANKOVIC RICHARD | Director | Buy | M | 13.45 | 5,764 | 77,507 | 7,853 | 2.1 K to 7.9 K (+275.92 %) |
Oct 22 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 10,000 | 265,800 | 31,320 | ||
Oct 22 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 54.28 | 10,000 | 542,800 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Oct 22 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 10,000 | 265,800 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Oct 19 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 10,000 | 265,800 | 41,320 | ||
Oct 19 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 54.70 | 10,000 | 547,047 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Oct 19 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 10,000 | 265,800 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Oct 18 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 5,400 | 143,532 | 51,320 | ||
Oct 18 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 10,000 | 265,800 | 56,720 | ||
Oct 18 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 55.46 | 5,400 | 299,494 | 133,077 | 138.5 K to 133.1 K (-3.90 %) | |
Oct 18 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 5,400 | 143,532 | 138,477 | 133.1 K to 138.5 K (+4.06 %) | |
Oct 18 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 55.21 | 10,000 | 552,079 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Oct 18 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 10,000 | 265,800 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Oct 12 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 10,000 | 265,800 | 66,720 | ||
Oct 12 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 55.75 | 10,000 | 557,525 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Oct 12 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 10,000 | 265,800 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Oct 11 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 10,000 | 265,800 | 86,720 | ||
Oct 11 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 55.61 | 10,000 | 556,120 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Oct 11 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 10,000 | 265,800 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Oct 10 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 10,000 | 265,800 | 86,720 | ||
Oct 10 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 55.78 | 10,000 | 557,834 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Oct 10 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 10,000 | 265,800 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Oct 09 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 36.33 | 7,196 | 261,407 | 25,000 | ||
Oct 09 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 56.00 | 7,196 | 402,976 | 133,077 | 140.3 K to 133.1 K (-5.13 %) | |
Oct 09 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 36.33 | 7,196 | 261,407 | 140,273 | 133.1 K to 140.3 K (+5.41 %) | |
Oct 03 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 36.33 | 3,800 | 138,041 | 32,196 | ||
Oct 03 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 36.33 | 56,503 | 2,052,568 | 35,996 | ||
Oct 03 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 57.11 | 3,800 | 217,035 | 133,077 | 136.9 K to 133.1 K (-2.78 %) | |
Oct 03 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 36.33 | 3,800 | 138,041 | 136,877 | 133.1 K to 136.9 K (+2.86 %) | |
Oct 03 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 56.92 | 2,727 | 155,230 | 133,077 | 135.8 K to 133.1 K (-2.01 %) | |
Oct 03 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 57.50 | 11,503 | 661,423 | 135,804 | 147.3 K to 135.8 K (-7.81 %) | |
Oct 03 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 56.89 | 42,273 | 2,404,848 | 147,307 | 189.6 K to 147.3 K (-22.30 %) | |
Oct 03 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 36.33 | 56,503 | 2,052,568 | 189,580 | 133.1 K to 189.6 K (+42.46 %) | |
Oct 01 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 36.33 | 20,000 | 726,534 | 92,499 | ||
Oct 01 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 56.08 | 20,000 | 1,121,600 | 133,077 | 153.1 K to 133.1 K (-13.07 %) | |
Oct 01 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 36.33 | 20,000 | 726,534 | 153,077 | 133.1 K to 153.1 K (+15.03 %) | |
Oct 01 2007 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Director | Sell | S | 56.00 | 1,300 | 72,800 | 159,760 | 161.1 K to 159.8 K (-0.81 %) |
Oct 01 2007 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Director | Sell | S | 52.50 | 5,000 | 262,500 | 164,060 | 169.1 K to 164.1 K (-2.96 %) |
Sep 27 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 36.33 | 25,000 | 908,168 | 112,499 | ||
Sep 27 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 55.86 | 25,000 | 1,396,473 | 133,077 | 158.1 K to 133.1 K (-15.82 %) | |
Sep 27 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 36.33 | 25,000 | 908,168 | 158,077 | 133.1 K to 158.1 K (+18.79 %) | |
Sep 26 2007 | BRL | BARR PHARMACEUTICA ... | STEPHAN GEORGE | Director | Sell | S | 54.60 | 19,968 | 1,090,253 | 149,092 | 169.1 K to 149.1 K (-11.81 %) |
Sep 25 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 24.57 | 45,000 | 1,105,502 | 0 | ||
Sep 25 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 54.26 | 25,000 | 1,356,500 | 133,077 | 158.1 K to 133.1 K (-15.82 %) | |
Sep 25 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 54.25 | 20,000 | 1,085,050 | 158,077 | 178.1 K to 158.1 K (-11.23 %) | |
Sep 25 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 24.57 | 45,000 | 1,105,502 | 178,077 | 133.1 K to 178.1 K (+33.82 %) | |
Sep 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 24.57 | 10,000 | 245,667 | 45,000 | ||
Sep 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 24.57 | 10,000 | 245,667 | 55,000 | ||
Sep 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 54.00 | 10,000 | 540,000 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Sep 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 24.57 | 10,000 | 245,667 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Sep 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 53.13 | 10,000 | 531,250 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Sep 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 24.57 | 10,000 | 245,667 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Sep 20 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 24.57 | 10,000 | 245,667 | 65,000 | ||
Sep 20 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 53.10 | 10,000 | 530,979 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Sep 20 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 24.57 | 10,000 | 245,667 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Sep 13 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 24.57 | 5,000 | 122,834 | 80,000 | ||
Sep 13 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 52.00 | 5,000 | 260,002 | 133,077 | 138.1 K to 133.1 K (-3.62 %) | |
Sep 13 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 24.57 | 5,000 | 122,834 | 138,077 | 133.1 K to 138.1 K (+3.76 %) | |
Sep 17 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 24.57 | 5,000 | 122,834 | 75,000 | ||
Sep 17 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 51.24 | 5,000 | 256,218 | 133,077 | 138.1 K to 133.1 K (-3.62 %) | |
Sep 17 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 24.57 | 5,000 | 122,834 | 138,077 | 133.1 K to 138.1 K (+3.76 %) | |
Sep 12 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | M | 24.57 | 5,000 | 122,834 | 85,000 |